Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - ENDONOVO THERAPEUTICS, INC. | Financial_Report.xls |
10-K - HANOVER 10-K 12/31/11 - ENDONOVO THERAPEUTICS, INC. | hanover10k_123111apg2.htm |
EX-32.1 - EXHIBIT 32.1 CERTIFICATION - ENDONOVO THERAPEUTICS, INC. | exhibit32_1apg.htm |
EX-31.1 - EXHIBIT 31.1 CERTIFICATION - ENDONOVO THERAPEUTICS, INC. | exhibit31_1apg.htm |
EX-31.2 - EXHIBIT 31.2 CERTIFICATION - ENDONOVO THERAPEUTICS, INC. | exhibit31_2apg.htm |
Exhibit 32.2
HANOVER PORTFOLIO ACQUISITIONS, INC.
SECTION 1350 CERTIFICATIONS
In connection with the Annual Report on Form 10-K of HANOVER PORTFOLIO ACQUISITIONS, INC., (the Company), for the period ended December 31, 2011, as filed with the Securities and Exchange Commission (the Report), I, Dean Skupen, Chief Financial Officer (Principal Financial Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
Date: April 13, 2012
|
|
|
| By: | /s/Dean Skupen |
|
| Dean Skupen |
|
| Chief Financial Officer (Principal Financial Officer) |